original ) (raw )Clinical and microbiological evaluation of temocillin for bloodstream infections with Enterobacterales: a Belgian single-centre retrospective study
Els Oris
JAC-Antimicrobial Resistance
View PDFchevron_right
Temocillin: Applications in Antimicrobial Stewardship as a Potential Carbapenem-Sparing Antibiotic
Tommaso Lupia
Antibiotics
View PDFchevron_right
Epidemiology of tetracycline-resistance determinants
Marilyn Roberts
Trends in Microbiology, 1994
View PDFchevron_right
Minimum inhibitory concentration of carbapenems and tigecycline against Salmonella spp
Deepthi Nair
Journal of Medical Microbiology, 2009
View PDFchevron_right
In vitro and in vivo Activity of Tigecycline/Colistin Combination Therapies against Carbapenem Resistant Enterobacteriaceae
David Wareham
Antimicrobial Agents and Chemotherapy, 2014
View PDFchevron_right
Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence
Theodoros Kelesidis
Journal of Antimicrobial Chemotherapy, 2008
View PDFchevron_right
A new bioassay method for quantitative analysis of tetracyclines
Núria Rius
2004
View PDFchevron_right
Development of Immunochromatographic Assay for Determination of Tetracycline in Human Serum
Anna Berlina
Antibiotics, 2018
View PDFchevron_right
Field method for the micro-quantitative determination of tetracycline in human blood serum
Syed Nabi
Journal of Pharmaceutical and Biomedical Analysis, 1998
View PDFchevron_right
In vitro susceptibility of multidrug-resistant Enterobacteriaceae clinical isolates to tigecycline
martha mushi
Journal of Antimicrobial Chemotherapy, 2012
View PDFchevron_right
Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance
Marilyn Roberts
Microbiology and Molecular Biology Reviews, 2001
View PDFchevron_right
Carbapenem sparing options for the treatment of ESBL and AmpC producing Enterobacteriaceae in hemodynamically stable patients an in vitro study
Aruna Poojary
2015
View PDFchevron_right
High prevalence of cross-resistance to fluoroquinolone and cotrimoxazole in tetracycline-resistant Escherichia coli human clinical isolates
Nathalie Caroff
Journal of Chemotherapy, 2016
View PDFchevron_right
Study on MICs of Tigecycline in Clinical Isolates of Carbapenem Resistant Enterobacteriaceae (CRE) at a Tertiary Care Centre in North India
Prashant Gupta
Journal of clinical and diagnostic research : JCDR, 2017
View PDFchevron_right
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
Drosos Karageorgopoulos
Journal of Antimicrobial Chemotherapy, 2008
View PDFchevron_right
Prevalence of tet genes mediating tetracycline resistance in Escherichia coli clinical isolates in Osun State, Nigeria
Samuel Sunday Taiwo
European Journal of Microbiology and Immunology
View PDFchevron_right
Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis
Kieran Killington
JAC-Antimicrobial Resistance, 2021
View PDFchevron_right
In vitro activity of temocillin against extended spectrum -lactamase-producing Escherichia coli
Marc Struelens
Journal of Antimicrobial Chemotherapy, 2006
View PDFchevron_right
Simultaneous determination of tetracyclines in pharmaceuticals by CZE using experimental design
Susanne Rath
Talanta, 2006
View PDFchevron_right
Occurrence of Tetracycline Resistance Genes among Escherichia coli Isolates from the Phase 3 Clinical Trials for Tigecycline
Anita Howe
Antimicrobial Agents and Chemotherapy, 2007
View PDFchevron_right
Tetracycline antibiotics
Bernd Schaefer
ChemTexts, 2021
View PDFchevron_right
In vitro activity of temocillin against prevalent extended-spectrum beta-lactamases producing Enterobacteriaceae from Belgian intensive care units
Marc Struelens
European Journal of Clinical Microbiology & Infectious Diseases, 2007
View PDFchevron_right
Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay
Georgia Vrioni
International Journal of Antimicrobial Agents, 2011
View PDFchevron_right
Prior use of carbapenems may be a significant risk factor for extended-spectrum -lactamase-producing Escherichia coli or Klebsiella spp. in patients with bacteraemia
Frederick Lopez
Journal of Antimicrobial Chemotherapy, 2006
View PDFchevron_right
Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems
Takahiko Fukuchi
View PDFchevron_right
Escherichia coli tetracycline efflux determinants in relation to tetracycline residues in chicken
Abdulkadir Elshafie
Asian Pacific journal of tropical medicine, 2013
View PDFchevron_right
Comparable outcomes for β-lactam/β-lactamase inhibitor combinations and carbapenems in definitive treatment of bloodstream infections caused by cefotaxime-resistant Escherichia coli or Klebsiella pneumoniae
Jaminah Ali
Antimicrobial Resistance and Infection Control, 2015
View PDFchevron_right
Effect of temocillin and moxalactam on platelet responsiveness and bleeding time in normal volunteers
B. Nunn
Antimicrobial Agents and Chemotherapy, 1985
View PDFchevron_right
Non-susceptibility to tigecycline in enterococci from hospitalised patients, food products and community sources
Luisa Peixe
International journal of antimicrobial agents, 2011
View PDFchevron_right
Temocillin (6 g daily) in critically ill patients: continuous infusion versus three times daily administration
Johan Mouton
Journal of Antimicrobial Chemotherapy, 2014
View PDFchevron_right
Evaluation of Combined Use of Temocillin Disk and Mastdisks Inhibitor Combination Set Against Polymerase Chain Reaction for Detection of Carbapenem-Resistant Enterobacteriaceae
Shereen Elmasry
Open Access Macedonian Journal of Medical Sciences, 2018
View PDFchevron_right